Detalhe da pesquisa
1.
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Oncologist
; 15(8): 799-809, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20671105
2.
[Satisfaction of Breast Cancer patients treated by chemotherapy outpatient clinics: Results of the TemporELLES survey]. / Satisfaction des patientes traitées par chimiothérapie en hôpital de jour pour un cancer du sein : résultats de l'enquête TemporELLES.
Bull Cancer
; 102(4): 316-23, 2015 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-25818929
3.
Longitudinal changes in serum HER-2/neu oncoprotein levels in trastuzumab-treated metastatic breast cancer patients.
Anticancer Res
; 24(2C): 1083-9, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15154627
4.
A randomized, double-blind trial assessing the efficacy and safety of sublingual metopimazine and ondansetron in the prophylaxis of chemotherapy-induced delayed emesis.
Anticancer Drugs
; 17(2): 217-24, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16428941